212 related articles for article (PubMed ID: 18701470)
1. Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.
Concannon P; Haile RW; Børresen-Dale AL; Rosenstein BS; Gatti RA; Teraoka SN; Diep TA; Jansen L; Atencio DP; Langholz B; Capanu M; Liang X; Begg CB; Thomas DC; Bernstein L; Olsen JH; Malone KE; Lynch CF; Anton-Culver H; Bernstein JL;
Cancer Res; 2008 Aug; 68(16):6486-91. PubMed ID: 18701470
[TBL] [Abstract][Full Text] [Related]
2. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.
Bernstein JL; Haile RW; Stovall M; Boice JD; Shore RE; Langholz B; Thomas DC; Bernstein L; Lynch CF; Olsen JH; Malone KE; Mellemkjaer L; Borresen-Dale AL; Rosenstein BS; Teraoka SN; Diep AT; Smith SA; Capanu M; Reiner AS; Liang X; Gatti RA; Concannon P;
J Natl Cancer Inst; 2010 Apr; 102(7):475-83. PubMed ID: 20305132
[TBL] [Abstract][Full Text] [Related]
3. Rare variants in the ATM gene and risk of breast cancer.
Goldgar DE; Healey S; Dowty JG; Da Silva L; Chen X; Spurdle AB; Terry MB; Daly MJ; Buys SM; Southey MC; Andrulis I; John EM; ; ; Khanna KK; Hopper JL; Oefner PJ; Lakhani S; Chenevix-Trench G
Breast Cancer Res; 2011 Jul; 13(4):R73. PubMed ID: 21787400
[TBL] [Abstract][Full Text] [Related]
4. Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry.
Bernstein JL; Teraoka S; Southey MC; Jenkins MA; Andrulis IL; Knight JA; John EM; Lapinski R; Wolitzer AL; Whittemore AS; West D; Seminara D; Olson ER; Spurdle AB; Chenevix-Trench G; Giles GG; Hopper JL; Concannon P
Hum Mutat; 2006 Nov; 27(11):1122-8. PubMed ID: 16958054
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of ATM missense variants and their contribution to contralateral breast cancer.
Broeks A; Braaf LM; Huseinovic A; Schmidt MK; Russell NS; van Leeuwen FE; Hogervorst FB; Van 't Veer LJ
Breast Cancer Res Treat; 2008 Jan; 107(2):243-8. PubMed ID: 17393301
[TBL] [Abstract][Full Text] [Related]
6. Screening for ATM sequence alterations in African-American women diagnosed with breast cancer.
Hirsch AE; Atencio DP; Rosenstein BS
Breast Cancer Res Treat; 2008 Jan; 107(1):139-44. PubMed ID: 17333338
[TBL] [Abstract][Full Text] [Related]
7. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.
Renwick A; Thompson D; Seal S; Kelly P; Chagtai T; Ahmed M; North B; Jayatilake H; Barfoot R; Spanova K; McGuffog L; Evans DG; Eccles D; ; Easton DF; Stratton MR; Rahman N
Nat Genet; 2006 Aug; 38(8):873-5. PubMed ID: 16832357
[TBL] [Abstract][Full Text] [Related]
8. The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer.
Stredrick DL; Garcia-Closas M; Pineda MA; Bhatti P; Alexander BH; Doody MM; Lissowska J; Peplonska B; Brinton LA; Chanock SJ; Struewing JP; Sigurdson AJ
Hum Mutat; 2006 Jun; 27(6):538-44. PubMed ID: 16652348
[TBL] [Abstract][Full Text] [Related]
9. Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia.
Olsen JH; Hahnemann JM; Børresen-Dale AL; Tretli S; Kleinerman R; Sankila R; Hammarström L; Robsahm TE; Kääriäinen H; Bregård A; Brøndum-Nielsen K; Yuen J; Tucker M
Br J Cancer; 2005 Jul; 93(2):260-5. PubMed ID: 15942625
[TBL] [Abstract][Full Text] [Related]
10. Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.
Tavtigian SV; Oefner PJ; Babikyan D; Hartmann A; Healey S; Le Calvez-Kelm F; Lesueur F; Byrnes GB; Chuang SC; Forey N; Feuchtinger C; Gioia L; Hall J; Hashibe M; Herte B; McKay-Chopin S; Thomas A; Vallée MP; Voegele C; Webb PM; Whiteman DC; ; ; ; Sangrajrang S; Hopper JL; Southey MC; Andrulis IL; John EM; Chenevix-Trench G
Am J Hum Genet; 2009 Oct; 85(4):427-46. PubMed ID: 19781682
[TBL] [Abstract][Full Text] [Related]
11. Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer.
Reiner AS; Robson ME; Mellemkjær L; Tischkowitz M; John EM; Lynch CF; Brooks JD; Boice JD; Knight JA; Teraoka SN; Liang X; Woods M; Shen R; Shore RE; Stram DO; Thomas DC; Malone KE; Bernstein L; Riaz N; Woodward W; Powell S; Goldgar D; Concannon P; ; Bernstein JL
J Natl Cancer Inst; 2020 Dec; 112(12):1275-1279. PubMed ID: 32119081
[TBL] [Abstract][Full Text] [Related]
12. Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study.
Broeks A; Braaf LM; Huseinovic A; Nooijen A; Urbanus J; Hogervorst FB; Schmidt MK; Klijn JG; Russell NS; Van Leeuwen FE; Van 't Veer LJ
Breast Cancer Res; 2007; 9(2):R26. PubMed ID: 17428320
[TBL] [Abstract][Full Text] [Related]
13. Multi-center screening of mutations in the ATM gene among women with breast cancer - the WECARE Study.
Berstein JL; Concannon P; Langholz B; Thompson WD; Bernstein L; Stovall M; Thomas DC;
Radiat Res; 2005 Jun; 163(6):698-9. PubMed ID: 16044499
[No Abstract] [Full Text] [Related]
14. Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study.
Bernstein JL; Langholz B; Haile RW; Bernstein L; Thomas DC; Stovall M; Malone KE; Lynch CF; Olsen JH; Anton-Culver H; Shore RE; Boice JD; Berkowitz GS; Gatti RA; Teitelbaum SL; Smith SA; Rosenstein BS; Børresen-Dale AL; Concannon P; Thompson WD;
Breast Cancer Res; 2004; 6(3):R199-214. PubMed ID: 15084244
[TBL] [Abstract][Full Text] [Related]
15. ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer.
Bernstein JL; Bernstein L; Thompson WD; Lynch CF; Malone KE; Teitelbaum SL; Olsen JH; Anton-Culver H; Boice JD; Rosenstein BS; Børresen-Dale AL; Gatti RA; Concannon P; Haile RW;
Br J Cancer; 2003 Oct; 89(8):1513-6. PubMed ID: 14562025
[TBL] [Abstract][Full Text] [Related]
16. Contribution of mutations in ATM to breast cancer development in the Czech population.
Soukupova J; Dundr P; Kleibl Z; Pohlreich P
Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
[TBL] [Abstract][Full Text] [Related]
17. Cancer risks and mortality in heterozygous ATM mutation carriers.
Thompson D; Duedal S; Kirner J; McGuffog L; Last J; Reiman A; Byrd P; Taylor M; Easton DF
J Natl Cancer Inst; 2005 Jun; 97(11):813-22. PubMed ID: 15928302
[TBL] [Abstract][Full Text] [Related]
18. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
[TBL] [Abstract][Full Text] [Related]
19. ATM, radiation, and the risk of second primary breast cancer.
Bernstein JL; ; Concannon P
Int J Radiat Biol; 2017 Oct; 93(10):1121-1127. PubMed ID: 28627265
[TBL] [Abstract][Full Text] [Related]
20. Association of common ATM variants with familial breast cancer in a South American population.
González-Hormazábal P; Bravo T; Blanco R; Valenzuela CY; Gómez F; Waugh E; Peralta O; Ortuzar W; Reyes JM; Jara L
BMC Cancer; 2008 Apr; 8():117. PubMed ID: 18433505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
